Norden Group LLC Raises Holdings in STERIS plc (NYSE:STE)

Norden Group LLC increased its stake in shares of STERIS plc (NYSE:STE) by 2.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,023 shares of the medical equipment provider’s stock after purchasing an additional 115 shares during the period. Norden Group LLC’s holdings in STERIS were worth $827,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Ashton Thomas Securities LLC acquired a new position in shares of STERIS in the third quarter worth $25,000. Human Investing LLC purchased a new stake in STERIS during the 4th quarter worth about $31,000. Anfield Capital Management LLC raised its stake in STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock valued at $37,000 after purchasing an additional 91 shares during the last quarter. Central Pacific Bank Trust Division lifted its holdings in STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC boosted its stake in shares of STERIS by 182.7% during the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 137 shares during the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on STE. Piper Sandler boosted their price objective on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research note on Friday, November 8th. JMP Securities reissued a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research note on Thursday, February 6th. Finally, Stephens reaffirmed an “overweight” rating and issued a $240.00 price objective on shares of STERIS in a research report on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $258.75.

STERIS Stock Performance

Shares of STE stock opened at $219.23 on Monday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The firm has a market capitalization of $21.54 billion, a price-to-earnings ratio of 46.54 and a beta of 0.84. STERIS plc has a one year low of $197.82 and a one year high of $248.24. The company has a 50 day moving average price of $214.99 and a 200 day moving average price of $222.93.

STERIS (NYSE:STE) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Sell-side analysts anticipate that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be paid a $0.57 dividend. This represents a $2.28 annualized dividend and a dividend yield of 1.04%. The ex-dividend date of this dividend is Thursday, February 20th. STERIS’s dividend payout ratio is currently 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.